Accelerating response to antidepressant treatment in depression

A review and clinical suggestions

Shinichiro Nakajima, Takefumi Suzuki, Koichiro Watanabe, Haruo Kashima, Hiroyuki Uchida

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Objective: The primary objective of this article is to review the literature regarding the speed of response to antidepressant drugs and potential strategies to accelerate the antidepressant response in new antidepressant-free patients with depression. Based on these data, we try to propose both an effective and safe antidepressant treatment strategy to alleviate depressive symptoms at the earliest opportunity. Data sources: Data were identified by searches of Medline (1966 to September 2009) and references from relevant articles and books. Search terms included depression, antidepressant, predictor, response, onset, acceleration, and augmentation. As our focus was on the acute phase treatment of depression, articles relevant to treatment-resistant depression were excluded. Only articles written in English or Japanese were consulted. Data selection: Studies, reviews, and books pertaining to the treatment of depression with a special regard to accelerating therapeutic effects were selected. Data synthesis: Most of the available treatment guidelines for major depressive disorders recommend the continuous use of antidepressants for 4 to 8. weeks based on the idea of a delayed onset of response to these drugs. Contrary to this conventional belief, the recent data indicate that antidepressants start to exert their effects within 2. weeks and early non-response could predict a subsequent unfavorable outcome. Conclusions: These findings suggest the need of revisiting the timing of an antidepressant switch for early non-responders, whereby switching could be commenced in as early as 2. weeks.

Original languageEnglish
Pages (from-to)259-264
Number of pages6
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume34
Issue number2
DOIs
Publication statusPublished - 2010 Mar

Fingerprint

Antidepressive Agents
Depression
Therapeutics
Treatment-Resistant Depressive Disorder
Information Storage and Retrieval
Major Depressive Disorder
Therapeutic Uses
Guidelines
Pharmaceutical Preparations

Keywords

  • Antidepressant
  • Early non-response
  • Major depressive disorder
  • Predictor
  • Switching

ASJC Scopus subject areas

  • Biological Psychiatry
  • Pharmacology

Cite this

Accelerating response to antidepressant treatment in depression : A review and clinical suggestions. / Nakajima, Shinichiro; Suzuki, Takefumi; Watanabe, Koichiro; Kashima, Haruo; Uchida, Hiroyuki.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 34, No. 2, 03.2010, p. 259-264.

Research output: Contribution to journalArticle

@article{683e16ab291b4fb1b54aa2e37285c668,
title = "Accelerating response to antidepressant treatment in depression: A review and clinical suggestions",
abstract = "Objective: The primary objective of this article is to review the literature regarding the speed of response to antidepressant drugs and potential strategies to accelerate the antidepressant response in new antidepressant-free patients with depression. Based on these data, we try to propose both an effective and safe antidepressant treatment strategy to alleviate depressive symptoms at the earliest opportunity. Data sources: Data were identified by searches of Medline (1966 to September 2009) and references from relevant articles and books. Search terms included depression, antidepressant, predictor, response, onset, acceleration, and augmentation. As our focus was on the acute phase treatment of depression, articles relevant to treatment-resistant depression were excluded. Only articles written in English or Japanese were consulted. Data selection: Studies, reviews, and books pertaining to the treatment of depression with a special regard to accelerating therapeutic effects were selected. Data synthesis: Most of the available treatment guidelines for major depressive disorders recommend the continuous use of antidepressants for 4 to 8. weeks based on the idea of a delayed onset of response to these drugs. Contrary to this conventional belief, the recent data indicate that antidepressants start to exert their effects within 2. weeks and early non-response could predict a subsequent unfavorable outcome. Conclusions: These findings suggest the need of revisiting the timing of an antidepressant switch for early non-responders, whereby switching could be commenced in as early as 2. weeks.",
keywords = "Antidepressant, Early non-response, Major depressive disorder, Predictor, Switching",
author = "Shinichiro Nakajima and Takefumi Suzuki and Koichiro Watanabe and Haruo Kashima and Hiroyuki Uchida",
year = "2010",
month = "3",
doi = "10.1016/j.pnpbp.2009.12.001",
language = "English",
volume = "34",
pages = "259--264",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Accelerating response to antidepressant treatment in depression

T2 - A review and clinical suggestions

AU - Nakajima, Shinichiro

AU - Suzuki, Takefumi

AU - Watanabe, Koichiro

AU - Kashima, Haruo

AU - Uchida, Hiroyuki

PY - 2010/3

Y1 - 2010/3

N2 - Objective: The primary objective of this article is to review the literature regarding the speed of response to antidepressant drugs and potential strategies to accelerate the antidepressant response in new antidepressant-free patients with depression. Based on these data, we try to propose both an effective and safe antidepressant treatment strategy to alleviate depressive symptoms at the earliest opportunity. Data sources: Data were identified by searches of Medline (1966 to September 2009) and references from relevant articles and books. Search terms included depression, antidepressant, predictor, response, onset, acceleration, and augmentation. As our focus was on the acute phase treatment of depression, articles relevant to treatment-resistant depression were excluded. Only articles written in English or Japanese were consulted. Data selection: Studies, reviews, and books pertaining to the treatment of depression with a special regard to accelerating therapeutic effects were selected. Data synthesis: Most of the available treatment guidelines for major depressive disorders recommend the continuous use of antidepressants for 4 to 8. weeks based on the idea of a delayed onset of response to these drugs. Contrary to this conventional belief, the recent data indicate that antidepressants start to exert their effects within 2. weeks and early non-response could predict a subsequent unfavorable outcome. Conclusions: These findings suggest the need of revisiting the timing of an antidepressant switch for early non-responders, whereby switching could be commenced in as early as 2. weeks.

AB - Objective: The primary objective of this article is to review the literature regarding the speed of response to antidepressant drugs and potential strategies to accelerate the antidepressant response in new antidepressant-free patients with depression. Based on these data, we try to propose both an effective and safe antidepressant treatment strategy to alleviate depressive symptoms at the earliest opportunity. Data sources: Data were identified by searches of Medline (1966 to September 2009) and references from relevant articles and books. Search terms included depression, antidepressant, predictor, response, onset, acceleration, and augmentation. As our focus was on the acute phase treatment of depression, articles relevant to treatment-resistant depression were excluded. Only articles written in English or Japanese were consulted. Data selection: Studies, reviews, and books pertaining to the treatment of depression with a special regard to accelerating therapeutic effects were selected. Data synthesis: Most of the available treatment guidelines for major depressive disorders recommend the continuous use of antidepressants for 4 to 8. weeks based on the idea of a delayed onset of response to these drugs. Contrary to this conventional belief, the recent data indicate that antidepressants start to exert their effects within 2. weeks and early non-response could predict a subsequent unfavorable outcome. Conclusions: These findings suggest the need of revisiting the timing of an antidepressant switch for early non-responders, whereby switching could be commenced in as early as 2. weeks.

KW - Antidepressant

KW - Early non-response

KW - Major depressive disorder

KW - Predictor

KW - Switching

UR - http://www.scopus.com/inward/record.url?scp=77649272274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649272274&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2009.12.001

DO - 10.1016/j.pnpbp.2009.12.001

M3 - Article

VL - 34

SP - 259

EP - 264

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

IS - 2

ER -